HER2-Positive NSCLC Yields to Targeted Agents (CME/CE)

(MedPage Today) -- A majority of patients with HER2-positive lung cancer had objective responses or stable disease when they received anti-HER2 agents in addition to chemotherapy, a small clinical study showed.
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news